Screener
Kyverna Therapeutics, Inc. KYTX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219397
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity | ||
| Preferred stock, 10,000,000 shares authorized, $0.00001 par value, no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.00001 par value; 490,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 60,532,500 and 60,389,893 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. | 1 | 1 |
| Additional paid-in capital | 660,230 | 657,005 |
| Accumulated other comprehensive income/(loss) | (96) | 97 |
| Accumulated deficit | (464,555) | (424,827) |
| Total stockholders’ equity | 195,580 | 232,276 |
| Total liabilities and stockholders’ equity | $257,024 | $293,826 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kyverna Therapeutics, Inc.'s total liabilities & equity?
- Kyverna Therapeutics, Inc. (KYTX) reported total liabilities & equity of $257.02M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Kyverna Therapeutics, Inc.'s total liabilities & equity decreased by 1.4% year-over-year, from $260.66M to $257.02M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s total liabilities & equity?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s total liabilities & equity has grown at a 97.7% compound annual growth rate (CAGR), from $75.2M to $293.83M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Kyverna Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude